Eliem Therapeutics, Inc(NASDAQ:ELYM) 
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems in the United States. The compan...
Website: http://www.eliemtx.com
Founded: 2018
CEO: Bob Azelby
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 7.75
H 8.35
L 7.51
C 8.32
V 959,370
10EMA 8.32
20EMA 8.32
60EMA 8.32
120EMA 8.32
250EMA 8.32